Articles
This article will cover two new biotechnology companies utilizing nanotechnology or nanomedicine to create enhanced hair growth drugs or cures for gray hair. Before I get right into the overview of the new companies, I would like to share a foreword as it has occurred to me that the time is right for it. This…
Read More
Here are two new additions to the ever-growing list of companies working on new therapeutic treatments for baldness or androgenetic alopecia. Life Code – An Artificial Intelligence Wellness Company Life Code is an early stage biotech company which is developing therapies with the assistance of artificial intelligence. The company is based in Hong Kong and…
Read More
In this article, the founder of dNovo Inc. shares insights on his company’s background and current focus. Brief Interview With dNovo Hair Company FT: What is the story behind your team deciding to pursue cellular reprogramming as a cure for hair loss? It seems as though there would be a distinctive moment or revelation that…
Read MoreA subsidiary of a European pharmaceutical company has launched in the US to trial a new drug against pattern hair loss. Also, preclinical data from the stock market-traded company Omega Therapeutics is shown. Dermaliq DLQ01 Drug Candidate On January 18, 2022, Novaliq GmbH and strategic investment partners announced the formation of a Dermaliq Therapeutics Inc.,…
Read More
Bioneer Targets H2 2022 Euro Launch Of CosmeRNA: Update (3/9/22) Bioneer/siRNAgen has apparently been evaluating its CosmeRNA product for cosmetic regulatory approval in Germany over the past several months. Various news outlets in the Korean press reported on March 8, 2022 that CosmeRNA has received an “excellent” safety evaluation by Dermatest, an accredited agency based…
Read More
HMI-115 Phase 2 Trial Begins In China: Update (11/7/23) Just under 2 years since this original article was published, Hope Medicine has officially launched a phase 2 clinical trial for HMI-115 in China. The study is listed on ClinicalTrials.gov and the actualy start date of the trial was in September 2023. Details are as follows: …
Read More
Follicle Thought is pleased to announce a new company developing a cellular reprogramming technology for the purpose of hair regeneration, a potential true cure for hair loss. Enter dNovo After operating in stealth mode over the last several years, it appears that dNovo is ready to make some waves in the cellular reprogramming space. dNovo…
Read More
An interesting new hair growth patent has surfaced online from the Nichinichi Pharmaceutical Company of Japan. NF-1011 – Enterococcus faecalis Nichinichi Pharmaceutical Co. specializes in the research and development of lactic acid bacteria strains for therapeutic uses. The current flagship product of the company is called FK-23, a proprietary formulation of the Enterococcus faecalis bacteria.…
Read More
In this article we will hear about recent advances made by Epibiotech in their efforts to create an effective cell therapy for hair growth. Korean Biotech Specializing In Hair Follicle Research Below is a quick video displaying the company atmosphere at Epibiotech. This video is also shared on the homepage of Epibiotech’s website. Note, the…
Read MoreThis article contains a complete list and description of every known biotech and med-tech company working on a clinical therapy for hair loss prevention/hair growth from all phases spanning research to late-stage clinical trials in 2024. Over the past several years, the amount of new hair growth related technologies in development have multiplied like never…
Read More